| Literature DB >> 23351168 |
Fubiao Li1, Runhui Tian, Changjiu Yin, Xiaofan Dai, Hongliang Wang, Ning Xu, Kaimin Guo.
Abstract
Liposarcoma of the spermatic cord (LSC) is a rare condition characterized by a painless inguinal or scrotal mass. To our knowledge, only about 200 cases have been previously reported in the literature. These tumors are often mistaken for common scrotal swellings, such as hydroceles and hernias. We present a LSC case in which a definitive diagnosis was obtained upon histological examination. We also provide a literature review of other cases that have been reported.Entities:
Mesh:
Year: 2013 PMID: 23351168 PMCID: PMC3585812 DOI: 10.1186/1477-7819-11-18
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Figure 1The gross appearance of LSC. Macroscopic appearance of the surgical specimen showing an encapsulated mass of adipose tissue and a cut surface having a yellowish lipoma-like texture. The left testis was not infiltrated. (white arrow: normal testis; red blank arrow: tumor tissue).
Figure 2HE staining of LSC. Microscopically well-differentiated myxoid liposarcoma composed of mature adipose tissue and a few scattered lipoblasts (yellow arrow: mature fatty cells) (H&E ×400).
Characteristics and clinical course of published cases of liposarcoma of the spermatic cord
| 12 | 53 | NA | L.s | 6 × 7 | RO | WDL | 3 yr | Recurrence |
| 22 | 70 | 6 mo | R.s | 13 × 7 × 3.5 | RO | WDL | 6 yr | Recurrence |
| 32 | 34 | NA | L.s | 1.5 × 2.5 | RO | WDL | 4 yr | NRD |
| 42 | 56 | 10 yr | L.s | 8.5 × 7.5 × 4.5 | RO+rad | PDL, WDL | 18 mo | NRD |
| 52 | 53 | NA | L.s | NA | RO | DL | 18 mo | NRD |
| 62 | 71 | 2 yr | L.s | NA | RO | WDL | 3 mo | NRD |
| 75 | 59 | 5 yr | L.s | 50 × 27.5 × 15 (10.9 kg) | RO | WDL | 3 yr | NRD |
| 86 | 60 | 7 mo | R.s; RP | 14 × 3.8 × 3.5; 24 × 10 × 8 | TR; RO | WDL (St) | 4 yr | NRD |
| 97 | 71 | 5 mo | L.s | 9.5 × 5.5 | RO | DL | 4 mo | NRD |
| 108 | 52 | 3 mo | L.s | 0.4 | TR | WDL | 3 yr | NRD |
| 1110 | 69 | 1 yr | L.s | 16 × 6 × 5 | RO+rad | WDL (St) | NA | NA |
| 1211 | 53 | 6 mo | R.s | 7.5 × 4.5 × 4 | RO | WDL (St) | NA | NA |
| 1312 | 76 | 1 wk | L.s | 6 × 5 × 3 | TR | WDML | NA | NA |
| 1413 | 24 | 6 mo | R.s | 5 | TR | WDML | 1 yr | NRD |
| 1514 | 79 | 3 mo | L.s | 12 × 6 (730 g) | RO | ML | 1 yr | NRD |
| 1615 | 60 | 4 yr | R.s | 15 × 20 (760 g) | RO | WDML | NA | NA |
| 1716 | 44 | 1 yr | L.s | 20 × 15 | RO | WDL (St) | 1 yr | NRD |
| 1817 | 60 | 6 yr | R.s | 5 × 4 | RO | WDL | 3 yr | NRD |
| 1918 | 75 | 18 mo | L.s | 20 × 15 | RO | ML | NA | NA |
| 2018 | 54 | NA | L.s | 20 × 20 | RO | PL | NA | NA |
| 2119 | 73 | 6 mo | R.s | 15 × 10 × 14 | RO | WDL | 8 yr | NRD |
| 2219 | 47 | NA | R.s | 3 | RO | WDL | 20 mo | NRD |
| 2320 | 73 | 1 yr | R.s | 17 × 13 × 4 | RO rad | DL | 2 yr | NRD |
| 2420 | 68 | 1mo | R.s | 8 × 6 × 6 | RO | WDL (St) | 6 mo | NRD |
| 2522. | 73 | NA | L.s; RP | 4.1 × 3.5 × 3; 3.3 × 3.3 × 2 | RO; TR | NA | 6 mo | NRD |
| 2623 | 40 | NA | R.s | 50 × 50 × 35 (42 kg) | TR | WDL (St) | 12 mo | NRD |
| 2724 | 65 | NA | R.s | 34 × 22 × 17 (5,786 g) | RO | DL | 48 mo | NRD |
| 2825 | 75 | NA | NA | 14 × 8 × 9 | RO | PL | NA | NA |
| 2926 | 47 | 6 mo | L.s | 4 × 3 × 3; 4 × 2 × 2 | RO | WDML; A | 30 mo | NRD |
| 3027 | 73 | 18 mo | L.s | 10 × 8 × 7 | RO | ML | NA | NA |
| 3129 | 65 | 1 yr | R.s | 14 × 8 × 5 | RO | WDML | 3 mo | NRD |
| 3230 | 64 | 4 yr | L.s | 26 × 15 × 7 (785 g) | RO | WDL | 3 mo | NRD |
| 3332 | 57 | 1.5 yr | L.s | 11 × 7.5 × 5 | RO+rad | DL | 10 yr | NRD |
| 3432 | 60 | NA | R.s | 3 × 1.8 × 1.5 | RO | WDL (St) | 1 yr | Recurrence |
| 3533 | 57 | 1 yr | L.s | 9 × 6.5 | RO+rad | DL | NA | NA |
| 3634 | 66 | 3 mo | R.s | 5 × 10 | RO | PDML | 6 mo | Metastases |
| 3735 | 60 | 1 yr | L.s | 10 × 10 × 5 | RO | WDL (St) | 3 yr | Recurrence |
| 3836 | 48 | 2 yr | R.s | NA | RO | WDL | 3 yr | NRD |
| Our case | 53 | 2 yr | L.s | 6 × 5 × 3 | RO | WDML | 18 mo | NRD |
Abbreviations: A, angiolipoma; DL, dedifferentiated liposarcoma; L.s, left side; ML, myxoid liposarcoma; NA, not available; NRD, no recurrence of disease; PDL, poorly-differentiated liposarcoma; PDML, poorly-differentiated myxoid liposarcoma; PL, pleomorphic liposarcoma; rad, radiotherapy; R.s, right side; RO, radical orchiectomy; RP, retroperitoneum; St, sclerosing type; TR, tumor resection; WDL, well-differentiated liposarcoma; WDML, well-differentiated myxoid liposarcoma.